Bardoxolone study terminated by safety monitoring committee. PDF Print
Yahoo: Abbott Laboratories Inc said its partner, Reata Pharmaceuticals, was discontinuing a late-stage trial of their potential blockbuster treatment for chronic kidney disease and diabetes based on safety concerns raised by an independent safety committee.

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.